Bilaketaren emaitzak - C A Cull

  • Erakusten 1 - 9 emaitzak -- 9
Findu emaitzak
  1. 1
    Relationship Between Ethnicity and Glycemic Control, Lipid Profiles, and Blood Pressure During the First 9 Years of Type 2 Diabetes

    Relationship Between Ethnicity and Glycemic Control, Lipid Profiles, and Blood Pressure During the First 9 Years of Type 2 Diabetes nork Timothy M. E. Davis, C A Cull, Rury R. Holman

    Argitaratua 2001
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Impact of the Metabolic Syndrome on Macrovascular and Microvascular Outcomes in Type 2 Diabetes Mellitus

    Impact of the Metabolic Syndrome on Macrovascular and Microvascular Outcomes in Type 2 Diabetes Mellitus nork C A Cull, Christine C. Jensen, Ravi Retnakaran, Rury R. Holman

    Argitaratua 2007
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Risk Factors for Renal Dysfunction in Type 2 Diabetes

    Risk Factors for Renal Dysfunction in Type 2 Diabetes nork Ravi Retnakaran, C A Cull, Kerensa Thorne, Amanda Adler, Rury R. Holman

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Sulfonylurea Inadequacy

    Sulfonylurea Inadequacy nork Alex Wright, A C Burden, Richard Paisey, C A Cull, Rury R. Holman

    Argitaratua 2002
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)

    Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) nork Amanda Adler, Richard Stevens, Susan E. Manley, Rudy Bilous, C A Cull, Rury R. Holman, UKPDS Group

    Argitaratua 2003
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)

    Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75) nork Irene Stratton, C A Cull, Amanda Adler, David R. Matthews, H. A. W. Neil, Rury R. Holman

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51)

    Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51) nork Philip Clarke, Alastair Gray, Amanda Adler, Richard Stevens, Maria Raikou, C A Cull, Irene Stratton, R. R. Holman

    Argitaratua 2001
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71)

    IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) nork G. F. Bottazzo, Emanuele Bosi, C A Cull, Ezio Bonifacio, Mattia Locatelli, P. Zimmet, I. R. Mackay, Rury R. Holman

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)

    Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70) nork Timothy M. E. Davis, Alex Wright, Z Mehta, C A Cull, Irene Stratton, G. F. Bottazzo, Emanuele Bosi, Ian R. Mackay, Rury R. Holman

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: